Navigation Links
Cardio3 BioSciences Reports Positive Three-Month Data From its Clinical Trial of C-Cure(R) in Heart Failure
Date:6/29/2010

MONT-SAINT-GUIBERT, Belgium, June 29, 2010 /PRNewswire/ -- Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the treatment of cardiovascular diseases, today announces positive safety data and preliminary efficacy results from its clinical trial of C-Cure(R), a breakthrough stem cell therapy for heart failure.

Results showed C-Cure to have a very good safety profile with no adverse events related to C-Cure, as assessed by an independent board. The study is also examining a number of measures of efficacy. With three month follow up data in-hand, Cardio3 BioSciences has observed positive and encouraging trends in a number of physiological and clinical parameters. Meaningful differences were seen in ventricular size, ejection fraction and other measures of heart muscle activity in C-Cure treated patients when compared to control and to baseline. Partial data from a paired analysis of patients at six-months follow-up is suggestive of these beneficial trends being reinforced over time. Cardio3 Biosciences intends to publish the study results once the full six month dataset is available and has been analysed.

Dr Christian Homsy, CEO of Cardio3 BioSciences said: "The data so far from our trial is very encouraging. We showed that C-Cure is safe at three months. We also saw positive trends in other measures that suggest that C-Cure, as anticipated from animal model data, is acting on heart muscle in a way that could yield important clinical benefits. We now look forward to seeing the full six-month follow-up data and completing the analysis of the trial."

"With the confidence and experience gained from this trial, we are moving ahead with finalizing the design of our pi
'/>"/>

SOURCE Cardio3 BioSciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cardio3 BioSciences Presents Update on C-Cure(R) Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress
2. Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
5. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
9. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Look inside the new Preferred Solutions® catalog ... from fluid handling to instruments to supplies. Many items ... order. , Preferred Solutions features a full selection ... model for precise flow control and dispensing to I/P® ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 ... conjugates for cancer, today announced the appointment of Thomas C ... has over 20 years, development experience gained in the biotechnology ... "I am delighted to welcome Tom at this ...
(Date:1/15/2014)... January 15, 2014 This webinar will ... and clinical safety assessment in biosimilars. , Regulatory frameworks ... biosimilar drug development, however the complex nature of biopharmaceuticals ... safety and efficacy extremely challenging. Based on the specific ...
(Date:1/15/2014)... TX (PRWEB) January 15, 2014 More ... disease, and about 1 in 3 seniors will die ... source ). These jaw-dropping figures have shocked many Americans ... and, hopefully, help prevent these tragic age-related cognitive disorders. ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2
... Ion Trap MS n , , , ... Shaler, , Paul Shieh, and William S. Hancock, , , ... Protein Glycosylation , , , , The ... mass spectrometer with MS n , capability., , , ...
... , , , , , Andreas ... , , , , ... Thermo Finnigan LCQTMion , trap mass spectrometer with MS n capability. ... , Calmodulin (CaM) is the primary high-affinity Ca ...
... , , , , , ... in eukaryotic cell cultures , requires double-stranded molecules known ... licensed supplier of siRNA, offering a custom , ... directed against common target genes, and a Cancer , ...
Cached Biology Technology:Structural Analysis of Glycosylated Peptides in Complex Mixtures with , Ion Trap MSn 2Structural Analysis of Glycosylated Peptides in Complex Mixtures with , Ion Trap MSn 3Structural Analysis of Glycosylated Peptides in Complex Mixtures with , Ion Trap MSn 4Structural Analysis of Glycosylated Peptides in Complex Mixtures with , Ion Trap MSn 5Structural Analysis of Glycosylated Peptides in Complex Mixtures with , Ion Trap MSn 6Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray , Ion Trap Mass Spectrometry 2Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray , Ion Trap Mass Spectrometry 3Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray , Ion Trap Mass Spectrometry 4Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray , Ion Trap Mass Spectrometry 5Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray , Ion Trap Mass Spectrometry 6RNAi Gene Silencing System 2RNAi Gene Silencing System 3
(Date:4/17/2014)... in the Amazon help create tinderbox conditions for ... widespread forest loss during drought years, according to ... forests in the Amazon could reach a "tipping ... lead to large-scale loss of trees, making recovery ... geography, Penn State. , "We documented one of ...
(Date:4/17/2014)... conditions such as heart disease, epilepsy and pain, making ... there is still much scientists do not know about ... insight into the structure of sodium channels and, specifically, ... are responsible for ,fine-tuning, the activity of the channel. ... of the Journal of Biological Chemistry . , ...
(Date:4/17/2014)... Current Biology on April 17 have discovered ... Brazilian insects, which represent four distinct but related species ... example of an animal with sex-reversed genitalia. , ... animals, Neotrogla is the only example in ... Yoshizawa from Hokkaido University in Japan. , During copulation, ...
Breaking Biology News(10 mins):Drought and fire in the Amazon lead to sharp increases in forest tree mortality 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 3Structure of sodium channels different than previously believed 2In sex-reversed cave insects, females have the penises 2
... from the University of the Free State in South Africa ... Central Africa in Belgium (Rudy Jocqu) discovered very poorly known ... the species described are new to science. The study was ... What is really unique about purse-web spiders is that, ...
... hundred scientists will discuss recent developments in biofuel production ... ,Bioenergy trees, to be hosted by the National Institute ... 2011 ( www.newphytologist.org/bioenergy ). Over the last five years ... funded a series of research projects to develop poplars, ...
... plant scientists unravel the genomes of plant pathogens, comparisons ... strategies for the organisms that threaten crops. John McDowell, ... out similarities in the strategies of several devastating rusts ... the published findings of other scientists, McDowell observes shared ...
Cached Biology News:Fueled by trees: International New Phytologist Symposium on 2nd generation biofuels 2Comparison of genomes of plant parasites provides solid clues for response 2
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/L; 1 tube of 1, 000 units enzyme/tube w/Buffer II and MgCl2...
Taq DNA Polymerase (T. aquaticus), 4 x 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying En...
... Gold® DNA Polymerase is a chemically modified ... chemical moiety is attached to the enzyme, ... the first ramp of thermal cycling (when ... temperatures), the enzyme is inactive. The result ...
Taq DNA Polymerase (cloned), 250 units. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Polymerases....
Biology Products: